Journalology/ Peer Review/ Authorship

Citations 41-50 of 266 total displayed.

Past content (since Jan 1998):

Letters
Incomplete Financial Disclosure in a Study of Cell-Free Hemoglobin-Based Blood Substitutes and Risks of Myocardial Infarction and Death

Charles Natanson
JAMA 2008; 300: 1300-a. [Extract] [Full text] [PDF] [ Original Article ]  

Commentaries
Industry-Sponsored Clinical Research: A Broken System

Marcia Angell
JAMA 2008; 300: 1069-1071. [Extract] [Full text] [PDF]  

Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

Garret A. FitzGerald
JAMA 2008; 300: 900-a-901-a. [Extract] [Full text] [PDF]  

Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

Kent R. Johnson; Marissa N. D. Lassere
JAMA 2008; 300: 900. [Extract] [Full text] [PDF]  

Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

Steven Ferris; Douglas Galasko; Louis Kirby
JAMA 2008; 300: 901-b-902-b. [Extract] [Full text] [PDF]  

Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

Christopher J. Hawkey
JAMA 2008; 300: 901-a. [Extract] [Full text] [PDF]  

Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

Carlo Patrono
JAMA 2008; 300: 901. [Extract] [Full text] [PDF]  

Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

Serban-Dan Costa
JAMA 2008; 300: 902-a-903-a. [Extract] [Full text] [PDF]  

Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

Richard Balon
JAMA 2008; 300: 902. [Extract] [Full text] [PDF]  

Letters
Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies

Hean T. Ong; Jin S. Cheah
JAMA 2008; 300: 903-a-904-a. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27